ScholarWorks@Korea University College of Medicine: Park, Ji Young

Detailed Information

Park, Ji Young (박지영)

Anam Hospital (Department of Clinical Pharmacology and Toxicology, Anam Hospital)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

pharmacokinetics:16||Drug interaction:8||pharmacogenetics:8||Pharmacokinetics:8||Pglycoprotein:6||bioequivalence:5||CYP3A5*3:5||amlodipine:5||ABCG2:4||CYP2C8:4||c:4||Pharmacogenetics:4||CYP3A5:4||Rosiglitazone:3||genetic polymorphism:3||BCRP:3||pharmacodynamics:3||pharmacokinetic equivalence:3||polymorphism:3||pyrosequencing:3||cytochrome P450 3A5 (CYP3A5):3||teneligliptin:3||CYP2C9:3||Koreans:3||CYP3A4:3||clinical trial:2||clopidogrel:2||CYP4F2:2||montelukast:2||Clopidogrel:2||Sibutramine:2||Cytochrome P450:2||Fexofenadine:2||Bioavailability:2||Cytochrome P450 3A4 (CYP3A4):2||Loperamide:2||platelet aggregation:2||Polymorphism:2||Pyrosequencing:2||Pharmacodynamics:2||Quercetin:2||risperidone:2||Ketoconazole:2||salt substitution:2||drug interaction:2||dabigatran:2||simvastatin:2||Ethnic difference:2||bioavailability:2||SR26334:2||Bioequivalence:2||ABCB1:2||OATP2B1:2||SLCO2B1:2||Docetaxel:2||Genetic polymorphism:2||9hydroxyrisperidone:2||Aspirin:2||Genetic predictor:1||Genotype:1||Gliclazide:1||HPLC:1||Haloperidol:1||Hemodynamics:1||Human liver microsomes:1||In vitroin vivo prediction:1||Ketoprofen:1||Korean:1||Korean population:1||LCMS:1||LCMS/MS:1||Leflunomide:1||Levocetirizine:1||Linkage disequilibrium:1||Lipase:1||MDRTb:1||MS:1||Major depressive disorder:1||Metronidazole:1||NONMEM®:1||Normalphase liquid chromatography:1||Ofloxacin:1||P2Y(1):1||P2Y(12):1||P450:1||PLATELET REACTIVITY:1||Pharmaceutical salts:1||Pharmacokinetic study:1||Platelet aggregation:1||Platelet inhibitors:1||Polymorphisms:1||Polysorbate:1||Prehypertension:1||Probenecid:1||Prostate cancer:1||Pulse rate:1||QT:1||QTc:1||RESISTANCE:1||Rifampin:1||Samlodipine:1||SLC2A9:1||SLCO1B1:1||SNP:1||STENT THROMBOSIS:1||STI571:1||SULT1A1:1||SULT1A2:1||Saltforming drug:1||Schizophrenia:1||Semimicro column:1||Semimicrocolumn:1||Single nucleotide polymorphism:1||Singlenucleotide polymorphism:1||Sulfotransferase:1||Sunlight exposure:1||Synovial fluid:1||Tamsulosin:1||Tandem mass spectrometry:1||Tardive dyskinesia:1||Therapeutic drug monitoring:1||Ticagrelor:1||Tolbutamide:1||Tumor response:1||UDPglucurunosyl transferase:1||Uncinate fasciculus:1||Uric acid:1||VKORC1:1||VMAT1:1||Vitamin K1:1||Warfarin:1||acetaminophen:1||age:1||alpha1 acid glycoprotein:1||anticoagulation:1||antiplatelet drug:1||antithrombin III:1||atorvastatin:1||bioayailability:1||biomarkers:1||brainderived neurotrophic factor:1||carbamazepine:1||chiral drug:1||chiral switching:1||cholic acid:1||colorectal cancer:1||curcumin:1||cytochrome P450 (CYP3A5):1||cytochrome P450 2C19 (CYP2C19):1||cytochrome P450 2D6 (CYP2D6):1||cytochrome P450 3A (CYP3A):1||cytochrome P450 3A5:1||dabigatran acylglucuronide:1||dapagliflozin:1||dextromethorphan:1||diagnosis:1||donepezilpharmacokinetic:1||drugdrug interaction (DDI):1||druginduced liver injury:1||enantiomer:1||equivalence:1||equivalencepharmacokinetics:1||ethnic difference:1||febuxostat:1||fixeddose combination products:1||flavincontaining monooxygenase 3:1||gammaaminobutyric acid A receptor:1||gender:1||gene expression:1||gene polymorphisms:1||genetic:1||glimepiride:1||glivec:1||herbal drugs:1||imatinib:1||imatinib (gleevec):1||indothiazinone:1||integrin IIb3:1||interaction:1||interactions:1||interferongamma:1||leflunomide:1||linagliptin:1||losartan:1||lung cancer:1||major depression:1||memantine:1||mirtazapine:1||natural killer cell:1||oligonucleotide microarray:1||platelet:1||quetiapine:1||rifampin:1||rosiglitazone:1||serrated adenoma:1||serrated pathway:1||stereoselectivity:1||talin:1||teneligliptin sulfoxide:1||therapeutic drug monitoring:1||thrombin generation:1||treatment response:1||uric acid:1||varenicline oxalate:1||varenicline tartrate:1||.:1||warfarin:1||1:1||12 diglyceride:1||2Odilaurylracglycero3glutaric acid(6methylresorufin) ester:1||2hydroxy atorvastatin:1||441C>T:1||472G>A:1||5Fluorouracil (5FU):1||855C>T:1||923A>G:1||A77 1726:1||A771726:1||ABCB1 (MDR1):1||ABCG2 (BCRP):1||ADP:1||Acute coronary syndrome:1||Amlodipine:1||Antiobesity drug:1||Association:1||Atorvastatin:1||BMI:1||Benzodiazepine:1||Bicalutarnide:1||Blood pressure:1||CKD810:1||CPHP:1||CYP2B6:1||CYP2C19:1||CYP2D6:1||CYP4F2*3:1||Cancer:1||Carbamazepine:1||Catechin:1||Chloroquine:1||Chlorzoxazone, 6hydroxychlorzoxazone:1||Contraindication of comedication drugs:1||Cyclosporine:1||Cytochrome:1||Cytochrome P450 (P450):1||Cytochrome P450 2C8 (CYP2C8):1||Cytochrome P450 2E1 (CYP2E1):1||Dabigatran:1||Dabigatran acylglucuronide:1||Dabigatran etexilate:1||Deproteinization:1||Desethylchloroquine:1||Desmethylsibutramine (BTS 54 354):1||Didesmethylsibutramine (BTS 54 505):1||Diffusion tensor imaging:1||Distribution pharmacokinetics:1||Dopamine receptor:1||Drug interactions:1||Drug utilization review:1||ELISA:1||Effect compartment model:1||Enantioselective:1||FMO3:1||Fluorescence detection:1||

STATISTICS: Total View :12,667,262; Today View :4,512

RSS_1.0 RSS_2.0 ATOM_1.0

73, Goryeodae-ro, Seongbuk-gu, Seoul, Republic of Korea (02841)82-2-2286-1265

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE